ALK Email Format

Pharmaceutical Manufacturing
2,501-5,000 employees
Hoersholm, Denmark

ALK is a Danish pharmaceutical company specializing in allergy immunotherapy treatments, developing long-term solutions for respiratory and food allergies for patients worldwide.

Find contacts at ALK

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@alk.net

Company Overview

Industry
Pharmaceutical Manufacturing
Founded
1923
Headquarters
Hoersholm, Denmark
Revenue
$1B-$2.5B
FUNDING Stage
Public
Key Executives
Peter Halling (President & CEO), Claus Steensen Solje (Executive Vice President & CFO), Jens Noack Skaerbaek (CIO, SVP Global IT)

Tech Stack

Tealium

Marketing

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of ALK?

ALK uses the first.last format on alk.net, so Jane Smith would be jane.smith@alk.net.

What therapeutic areas does ALK focus on beyond respiratory allergy?

Beyond respiratory allergy, ALK focuses on anaphylaxis and food and venom allergy. The company launched the world's first nasal adrenaline spray for anaphylaxis in Germany and the UK in 2025 and has a peanut allergy sublingual immunotherapy tablet in development.

How many markets is ALK present in globally?

ALK operates in 46 markets worldwide with offices in more than 20 countries and production sites in Denmark, Spain, France, and the United States. If you need to find a specific ALK contact in a given region, a tool like Clay can help identify the right person quickly.

What are ALK's flagship sublingual immunotherapy tablet products?

ALK's best-known sublingual immunotherapy tablets include Grazax for grass pollen allergy and Acarizax for house dust mite allergy. These SLIT-tablets represent the core of ALK's product portfolio and account for the large majority of the company's revenues.

Who leads ALK as its chief executive?

Peter Halling serves as President and CEO of ALK, leading the company from its headquarters in Horsholm, Denmark. ALK employs around 3,094 people globally and is listed on Nasdaq Copenhagen.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles